Fabtech Technologies Limited

Fabtech Technologies Limited

Fabtech Technologies Limited's investor presentation for FY26 highlights a strong financial performance, with revenue from operations growing 25.7% YoY to ₹410.77 Cr and operational profit up 17.0% YoY to ₹36.60 Cr. The company reported a consolidated order book of over ₹900 Cr as of March 31, 2026, providing significant revenue visibility. Strategic wins include new projects in Animal Health, KSA vaccine and advanced pharma facilities, and large-scale African pharma infrastructure. Fabtech is expanding its global footprint and diversifying into high-growth sectors, demonstrating resilient performance despite geopolitical challenges and supply chain disruptions.

Fabtech Technologies Limited

Fabtech Technologies Limited announced an upcoming interaction with investors and analysts. The company's officials will participate in a physical group meeting titled "The Growth Exchange 2026 – Niveshak S" on Wednesday, June 24, 2026, in Mumbai at 05:30 p.m. This engagement is conducted under Regulation 30 of SEBI Listing Regulations. For investors, these interactions offer direct insights into the company's performance, strategy, and future outlook, which can influence their investment decisions.